首站-论文投稿智能助手
典型文献
Jug-PLGA-NPs,a New Form of Juglone with Enhanced Efficiency and Reduced Toxicity on Melanoma
文献摘要:
Objective:To verrify the anti-tumor efficacy and toxicity between juglone(Jug)and Jug-loaded poly lactic-co-glycolic acid(PLGA)nanoparticles(Jug-PLGA-NPs).Methods:Jug-PLGA-NPs were prepared by ultrasonic emulsification.The anti-tumor activity of Jug(2,3,4 μ g/mL)and Jug-PLGA-NPs(Jug:2,3,4 μ g/mL)in vitro was measured by MTT assay and cell apoptosis analysis.The distribution,anti-tumor effect and biological safety in vivo was evaluated on A375 nude mice.Results:With the advantage of good penetration and targeting properties,Jug-PLGA-NPs significantly inhibited proliferation and migration of melanoma cells both in vitro and in vivo(P<0.05 or P<0.01)with acceptable biocompatibility.Conclusions:Jug can inhibit the growth of melanoma but is highly toxic.With the advantage of sustained release,tumor targeting,anti-tumor activity and acceptable biological safety,Jug-PLGA-NPs provide a new pharmaceutical form for future application of Jug.
文献关键词:
作者姓名:
YUE Wu-heng;QIN Lan-qun;CAI Juan;MEI Rui;QIAN Han-qing;ZOU Zheng-yun
作者机构:
The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital,Clinical College of Traditional Chinese and Western Medicine,Nanjing University of Chinese Medicine,Nanjing 210008,China;Department of Oncology,Taicang TCM Hospital Affiliated to Nanjing University of Chinese Medicine,Suzhou,Jiangsu Province 215499,China;The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital,Clinical College of Nanjing Medical University,Nanjing 210008,China;The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital,Medical School of Nanjing University&Clinical Cancer Institute of Nanjing University,Nanjing 210008,China
引用格式:
[1]YUE Wu-heng;QIN Lan-qun;CAI Juan;MEI Rui;QIAN Han-qing;ZOU Zheng-yun-.Jug-PLGA-NPs,a New Form of Juglone with Enhanced Efficiency and Reduced Toxicity on Melanoma)[J].中国结合医学杂志(英文版),2022(10):909-917
A类:
Jug,Juglone,verrify,juglone
B类:
PLGA,NPs,New,Form,Enhanced,Efficiency,Reduced,Toxicity,Melanoma,Objective,anti,tumor,efficacy,toxicity,between,loaded,poly,lactic,glycolic,acid,nanoparticles,Methods,were,prepared,by,ultrasonic,emulsification,activity,vitro,was,measured,MTT,assay,apoptosis,analysis,distribution,effect,biological,safety,vivo,evaluated,A375,nude,mice,Results,With,advantage,good,penetration,targeting,properties,significantly,inhibited,proliferation,migration,melanoma,cells,both,acceptable,biocompatibility,Conclusions,growth,highly,sustained,release,provide,new,pharmaceutical,form,future,application
AB值:
0.470681
相似文献
Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity
Zhang Weiwei;Yan Wenji;Qian Niansong;Han Quanli;Zhang Weitao;Dai Guanghai-Chinese People’s Liberation Army Medical School, Beijing 100853, China;Department of the Third Health Care, The Second Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The First Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The Hainan Medical Center, Chinese People’s Liberation Army General Hospital, Sanya 572022, China;Cancer Center, Beijing Tongren Hospital Affiliated to Capital Medical University, Economic and Technological Development Zone, Beijing 100176, China
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners
Zhao Simin;Zheng Baisong;Wang Liuli;Cui Wenzhe;Jiang Chunlai;Li Zhuo;Gao Wenying;Zhang Wenyan-Center for Pathogen Biology and Infectious Diseases, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, Jilin 130021, China;College of Life Science of Jilin University, Changchun, Jilin 130012, China;Department of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130012, China;Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, Jilin 130041, China;Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, China
Taxifolin attenuates inflammation via suppressing MAPK signal pathway in vitro and in silico analysis
Xingyan Zhang;Xiaoyan Lian;Huling Li;Wenjing Zhao;Xin Li;Fujun Zhou;Yutong Zhou;Tao Cui;Yuli Wang;Changxiao Liu-Key Laboratory of Quality-marker of Traditional Chinese Medicines,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Center for Drug Evaluation,National Medical Products Administration,Beijing 100022,China;Department of Pharmacology,Tianjin Medical University,Tianjin 300070,China;State Key Laboratory of Drug Delivery Technology and Pharmacokinetics,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Key Laboratory of Systems Bioengineering(Ministry of Education),School of Chemistry Engineering and Technology,Tianjin University,Tianjin 300072,China;Pharmaceuticai Armaceuticai DA REN TANG Group Corporation Limited Traditional Chinese Pharmacy Researchinstitute,Tianjin 300457,China;Tianjin Key Laboratory of Quality Control in Chinese Medicine,Tianjin 300457,China;Research Unit for Drug Metabolism,Chinese Academy of Medical Sciences,Beijing 100730,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。